Table 2.
Correlations of Circ-SMARCA5 and miR-432 with Clinicopathologic Features.
| Items | Circ-SMARCA5 | P value | MiR-432 | P value | ||
|---|---|---|---|---|---|---|
| Low (n = 78) | High (n = 78) | Low (n = 78) | High (n = 78) | |||
| Age (years), No. (%) | .188 | .742 | ||||
| <60 years | 34 (43.6) | 26 (33.3) | 31 (39.7) | 29 (37.2) | ||
| ≥60 years | 44 (56.4) | 52 (66.7) | 47 (60.3) | 49 (62.8) | ||
| Gender, No. (%) | .254 | .704 | ||||
| Female | 15 (19.2) | 21 (26.9) | 19 (24.4) | 17 (21.8) | ||
| Male | 63 (80.8) | 57 (73.1) | 59 (75.6) | 61 (78.2) | ||
| Multiplicity, No. (%) | .172 | .040 | ||||
| Single | 57 (73.1) | 49 (62.8) | 47 (60.3) | 59 (75.6) | ||
| Multiple | 21 (26.9) | 29 (37.2) | 31 (39.7) | 19 (24.4) | ||
| Tumor size (cm), No. (%) | .016 | .042 | ||||
| <3 cm | 65 (83.3) | 52 (66.7) | 53 (67.9) | 64 (82.1) | ||
| ≥3 cm | 13 (16.7) | 26 (33.3) | 25 (32.1) | 14 (17.9) | ||
| Tumor stage, No. (%) | .015 | .005 | ||||
| Ta&T1 | 61 (78.2) | 47 (60.3) | 46 (59.0) | 62 (79.5) | ||
| T2-T4 | 17 (21.8) | 31 (39.7) | 32 (41.0) | 16 (20.5) | ||
| LYN metastasis, No. (%) | .043 | .043 | ||||
| No | 75 (96.2) | 68 (87.2) | 68 (87.2) | 75 (96.2) | ||
| Yes | 3 (3.8) | 10 (12.8) | 10 (12.8) | 3 (3.8) | ||
| Pathological grade, No. (%) | .101 | .190 | ||||
| Low | 53 (67.9) | 43 (55.1) | 44 (56.4) | 52 (66.7) | ||
| High | 25 (32.1) | 35 (44.9) | 34 (43.6) | 26 (33.3) | ||
Correlation was determined by Spearman's rank correlation test.
Abbreviations: circ-SMARCA5, circular RNA SMARCA5; miR-432, microRNA-432; LYN, lymph node.